Video

Chris Cannon, MD: New Dyslipidemia Guidelines & Global Health Implications

Author(s):

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Chris Cannon, MD, Brigham & Women's Hospital, discussed the latest changes with the dyslipidemia guidelines.

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Chris Cannon, MD, Brigham & Women's Hospital, discussed the latest changes with the dyslipidemia guidelines. Cannon emphasized the global implications of making sure physicians follow through with prevention, and suggested how important risk stratification is. He also explained the prevalence of under treatment, particularly in the US, and stressed the significance of open communication.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.